[1] 国家自然科学基金青年项目 lncRNA-p21/EZH2通路促进前列腺癌神经内分泌化机制研究，2019/01-2021/12，22万元，结题，参与

  [2] 同济大学学科交叉联合攻关项目，环境因素对尿钙水平及泌尿系结石发病率的影响，2023/07-2024/06，25万元，在研，项目负责人

 [3] 同济医院院级课题 肠镜辅助结肠粘膜重建尿道的研究 2015/5-2017/4，2万元，已结题，主持

(1) LiuBo; Jiang, Hui-Yang; Yuan, Tao; Luo, Jie;Zhou, Wei-Doug; Jiang, Qi-Quan; Wu, Denglong ; Enzalutamide-Induced Upregulation of PCAT6Promotes Prostate Cancer Neuroendocrine Differentiation by RegulatingmiR-326/HNRNPA2B1 Axis, Frontiers in Oncology, 2021, 11(650054)

(2) LiuBo; Qian, Duocheng; Zhou, Weidong; Jiang,Huiyang; Xiang, Zhendong; Wu, Denglong ; A Novel Androgen-Induced lncRNAFAM83H-AS1 Promotes Prostate Cancer Progression via the miR-15a/CCNE2 Axis, Frontiersin Oncology, 2021, 10(620306)

(3) Bo Liu; Hui-Yang, Jiang; Tao, Yuan; Wei-Dong,Zhou; Zhen-Dong, Xiang; Qi-Quan, Jiang; De ng-Long, Wu ; Long non-coding RNAAFAP1-AS1 facilitates prostate cancer progression by regulatingmiR-15b/IGF1Raxis, Current Pharmaceutical Design, 2021, 27(41): 4261-4269

(4) Bo Liu; Weidong, Zhou; Huiyang, Jiang; Zhendong,Xiang; Lei, Wang ; miR-1303 promotes the proliferation, migration and invasionof prostate cancer cells through regulating the Wnt/β-catenin pathway by targeting DKK3, Experimental andTherapeutic Medicine, 2019, 18(6): 4747-4757

(1) 刘博; 一种逆行尿道造影注射器, 2019-7-19, 中国, ZL2018220220900 (实用新型专利)

(2) 李超，刘博等。 一种尿道内支架及导尿管固定器。2017-1-16，中国， ZL201710030719.3（发明专利）